Amit Mahajan

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Scott Gettinger, Amit Mahajan et al. · The Lancet Oncology · 2016 · 987 citations · Full text

Neuro-oncology, Non-small-cell Lung Cancer, Untreated Brain Metastases +8

Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

Sarah B. Goldberg, Kurt A. Schalper, Scott Gettinger et al. · The Lancet Oncology · 2020 · 523 citations · Full text

Neuro-oncology, Prognostic Biomarkers, Biomarker Analysis +11

Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: One-Year Results of the Prospective, Multicenter NAVIGATE Study

Erik Folch, Michael A. Pritchett, Michael Nead et al. · Journal of Thoracic Oncology · 2018 · 393 citations · Full text

Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial

Harriet M. Kluger, Veronica Chiang, Amit Mahajan et al. · Journal of Clinical Oncology · 2018 · 275 citations

American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients With Suspected or Confirmed COVID-19 Infection

Momen M. Wahidi, Carla Lamb, Septimiu Murgu et al. · Journal of Bronchology & Interventional Pulmonology · 2020 · 234 citations · Full text

Effective Use, Global Spread, Interventional Pulmonology +17